Latest News

STAT Plus: Pharmalittle: FDA plans ‘concierge service’ for expanded access to cancer meds; Novartis ‘anchored’ gene therapy price

Top of the morning to you, and a fine one it is. A shiny sun and crisp breeze are enveloping the Pharmalot campus, where the short people have left for the local schoolhouse and gainful employment, respectively, leaving us with the official mascot to sort out the morning routine. And of course, this means we are, once again, firing up the coffee kettle for a cup of stimulation. And why not? The neurons can use a little help. Feel free to join us if you agree. Meanwhile, time to get cracking. Here are some items of interest. Hope you have a splendid day and, as always, do keep in touch. …

The Food and Drug Administration plans to provide “concierge service” to doctors seeking access to unapproved drugs for cancer patients who have no other treatment options, The Washington Post writes. The pilot will include Project Facilitate, a new call center run by the agency’s oncology staff to provide a single point of contact for doctors submitting requests for the program. Although the agency has streamlined its expanded-access program in recent years, the process still may seem confusing to doctors who have little experience with it.

Continue to STAT Plus to read the full story…

Source link

Related posts

Considering the Source of Information in the Evaluation of Maltreatment Experiences—Reply


Global Osteoarthritis Clinical Trials Review – H1, 2020 –


54 digital health mergers and acquisitions in 2018


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World